The Challenge of Bacterial Infections During Intensive Care Unit Stay After Heart Transplantation
Transplant Infectious Disease · 2025
DOI: 10.1111/tid.70031 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Transplant Infectious Disease, 2025. Verfasst von Rita Minucci und 10 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. Hauptthemen laut MEDLINE: Heart Transplantation, Pneumonia, Ventilator-Associated, Cross Infection, Bacteremia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Intensivpflege
Abstract (Originalsprache)
Background
Infections occurring in the early post–heart transplant (HT) period heavily contribute to morbidity and mortality. Our goal is to evaluate the incidence of hospital‐acquired pneumonia/ventilator‐associated pneumonia (HAP/VAPs) and/or bloodstream infections (BSIs) after HT during the intensive care unit (ICU) stay and identify their associated risk factors in our tertiary hospital.
Methods
Observational prospective study including all adult patients who consecutively underwent HT from January 1, 2015 to August 31, 2023 at Fondazione IRCCS Policlinico San Matteo, Pavia, Italy. HAP/VAPs and BSIs diagnosed during ICU were included in the analysis.
Results
A total of 106 patients were included, 38 of whom had at least one infectious episode (35.8%), for a total of 57 independent episodes and their incidence was 2.2 per 100 days (95% CI 1.7–2.8). Length of ICU stay was 8 days (IQR: 6–11) for patients without infectious events and 27 days (IQR 14–52) for those with infectious events ( p < 0.001). Gram‐negative bacteria were associated with 62.8% of BSIs (mainly Enterobacterales ) and with 77.9% of HAP/VAP, in this setting Pseudomonas aeruginosa accounted for 17.6% of infections while Klebsiella spp. accounted for 22.1% of infections. Colonization with resistant bacteria (HR 2.21, 95% CI 1.12–4.35) was associated with increased risk of infections while perioperative antimicrobial prophylaxis (PAP) covering Gram‐negative bacteria at transplant (HR 0.45, 95% CI 0.23–0.90, p = 0.023) was a protective factor.
Conclusion
This study shows that Gram‐negative infections represent the major challenge for HT patients during ICU stay and shows some evidence in support of the PAP covering Gram‐negative infections at transplant. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Diseases Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
- SSD Biostatistics and Clinical Trial Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
- Microbiology and Virology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
- Clinical, Surgical, Diagnostic and Pediatric Sciences Department, University of Pavia, Pavia, Italy.
- Cardiac Surgery Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
- Department of SC AR2-Anesthesia and Cardiothoracic ICU, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
ORCID-Profile: Elena Seminari
Zitieren
APA
Minucci, R., De Silvestri, A., Cambieri, P., Corbella, M., Pellegrini, C., Roda, S., Dezza, C., Pelenghi, S., Bruno, R., Belliato, M., & Seminari, E. (2025). The Challenge of Bacterial Infections During Intensive Care Unit Stay After Heart Transplantation. Transplant Infectious Disease. https://doi.org/10.1111/tid.70031
Vancouver
Minucci R, De Silvestri A, Cambieri P, Corbella M, Pellegrini C, Roda S, et al. The Challenge of Bacterial Infections During Intensive Care Unit Stay After Heart Transplantation. Transplant Infectious Disease. 2025. doi:10.1111/tid.70031
BibTeX
@article{Minucci2025,
author = {Minucci, Rita and De Silvestri, Annalisa and Cambieri, Patrizia and Corbella, Marta and Pellegrini, Carlo and Roda, Silvia and Dezza, Chiara and Pelenghi, Stefano and Bruno, Raffaele and Belliato, Mirko and Seminari, Elena},
title = {The Challenge of Bacterial Infections During Intensive Care Unit Stay After Heart Transplantation},
journal = {Transplant Infectious Disease},
year = {2025},
doi = {10.1111/tid.70031}
}
EUVIMED